Literature DB >> 9893126

Fibronectin augments monocyte adhesion to low-density lipoprotein-stimulated mesangial cells.

R S Chana1, D C Wheeler.   

Abstract

BACKGROUND: Glomerular monocyte infiltration is an early feature of lipid-mediated renal injury in animal models. Interactions between mesangial and infiltrating mononuclear cells may contribute to the development of glomerular scarring.
METHODS: Adherence of U-937 monocytes to low-density lipoprotein (LDL)- or tumor necrosis factor alpha (TNFalpha)-prestimulated human mesangial cells was assessed by colorimetry of nuclear staining with crystal violet. Blocking antibodies were added to examine the mechanisms of binding. Adhesion molecule expression and fibronectin synthesis were measured by ELISA.
RESULTS: Preincubation of mesangial cells for 24 hours with LDL (100 micrograms/ml) or mildly oxidized (minimally modified) LDL (MM-LDL) increased monocyte adhesion by 207% and 240%, respectively, compared with control nonstimulated cells (100%). TNFalpha (100 U/ml) enhanced binding by 335% and up-regulated intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression by 505% and 179%, respectively, as compared with MM-LDL (120% and 116%) and LDL, which had no effect. Blocking antibodies to these adhesion molecules inhibited monocyte binding to TNFalpha- and, to a lesser extent, MM-LDL-primed mesangial cells, but had no effect after LDL pretreatment. In contrast to TNFalpha, MM-LDL and LDL increased mesangial cell-associated fibronectin, whereas antibodies to fibronectin inhibited monocyte binding to lipoprotein-stimulated but not TNFalpha-stimulated cells.
CONCLUSIONS: Although enhanced monocyte adhesion to TNFalpha- and, to a lesser extent, MM-LDL-stimulated mesangial cells is mediated by changes in ICAM-1 and VCAM-1 expression, both LDL and MM-LDL promote similar cellular interactions as a result of increased fibronectin production.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9893126     DOI: 10.1046/j.1523-1755.1999.00250.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Human renal mesangial cells are a target for the anti-inflammatory action of 9-cis retinoic acid.

Authors:  V M Manzano; J C Muñoz; J R Jiménez; M R Puyol; D R Puyol; M Kitamura; F J Cazaña
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  The leaf extract of Ginkgo Biloba L. suppresses oxidized LDL-stimulated fibronectin production through an antioxidant action in rat mesangial cells.

Authors:  Satoshi Akiba; Masahiro Chiba; Yuki Mukaida; Akira Tamura; Takashi Sato
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

3.  Retinoids as a potential treatment for experimental puromycin-induced nephrosis.

Authors:  V Moreno-Manzano; F Mampaso; J C Sepúlveda-Muñoz; M Alique; S Chen; F N Ziyadeh; M C Iglesias-de la Cruz; J Rodríguez; E Nieto; J M Orellana; P Reyes; I Arribas; Q Xu; M Kitamura; F J Lucio Cazana
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

4.  Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy.

Authors:  Cong Wang; Qian Li; Junhui Zhen; Yihuai Xu; Shuzhen Sun
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

5.  Fulvic Acid Attenuates Resistin-Induced Adhesion of HCT-116 Colorectal Cancer Cells to Endothelial Cells.

Authors:  Wen-Shih Huang; Jen-Tsung Yang; Chien-Chang Lu; Shun-Fu Chang; Cheng-Nan Chen; Yu-Ping Su; Ko-Chao Lee
Journal:  Int J Mol Sci       Date:  2015-12-09       Impact factor: 5.923

6.  The tripeptide feG inhibits leukocyte adhesion.

Authors:  Ronald D Mathison; Emily Christie; Joseph S Davison
Journal:  J Inflamm (Lond)       Date:  2008-05-20       Impact factor: 4.981

7.  Increased serum CXCL16 is highly correlated with blood lipids, urine protein and immune reaction in children with active nephrotic syndrome.

Authors:  Junhui Zhen; Qian Li; Yanji Zhu; Xiujun Yao; Li Wang; Aihua Zhou; Shuzhen Sun
Journal:  Diagn Pathol       Date:  2014-01-24       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.